Related Experiment Videos
Cerebral metabolic changes in biotinidase deficiency
M Schürmann1, V Engelbrecht, K Lohmeier
1Department of Paediatrics, Heinrich-Heine-University, Düsseldorf, Germany.
Journal of Inherited Metabolic Disease
|January 14, 1998
Summary
Biotinidase deficiency treatment improved patients, but neurological issues and brain lactate persisted. Intracerebral metabolite measurement is key to understanding this rare metabolic disorder.
Area of Science:
- Biochemistry
- Neurology
- Metabolic Disorders
Background:
- Biotinidase deficiency is a rare inherited metabolic disorder affecting the central nervous system.
- Early diagnosis and biotin supplementation are crucial for managing the condition.
Observation:
- A patient with biotinidase deficiency was studied before and after biotin treatment.
- Metabolic markers including lactate, pyruvate, and 3-hydroxyisovaleric acid were measured in blood, cerebrospinal fluid, and brain tissue.
Findings:
- The patient showed significant clinical improvement with biotin treatment.
- Despite normalized extracerebral markers, persistent neurological deficits and abnormal intracerebral lactate concentrations were observed.
- Localized in vivo magnetic resonance spectroscopy revealed persistent metabolic abnormalities within the brain.
Implications:
- Intracerebral metabolite measurements are vital for understanding the pathogenesis of biotinidase deficiency.
- This technique may offer insights into persistent neurological sequelae despite systemic metabolic correction.
- Further research using in vivo spectroscopy could refine treatment strategies for metabolic encephalopathies.